Welcome to our dedicated page for Maxlinear SEC filings (Ticker: MXL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MaxLinear, Inc.'s SEC filings document its public-company disclosures as a semiconductor issuer focused on RF, analog, digital and mixed-signal integrated circuits. Recent 8-K filings cover quarterly operating results, material agreements, credit-facility amendments, share repurchase authorization and governance changes.
Proxy materials describe board structure, director elections, committee service, executive compensation, equity awards and shareholder voting matters. The filing record also reflects capital-structure items tied to common stock, revolving credit arrangements, subsidiary participation in financing agreements and the risk and governance disclosures associated with MaxLinear’s operating business.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice of proposed sales of Common Stock. The filing lists multiple blocks of restricted stock, performance shares and Employee Stock Purchase Plan shares with specific grant dates and share counts (examples: 227, 1,430, 2,621), dated between 02/20/2021 and 02/03/2023.
MaxLinear reported stronger results for the three months ended March 31, 2026, with net revenue of $137.2 million, up from $95.9 million a year earlier, driven mainly by infrastructure and broadband demand.
The company still posted a net loss of $45.1 million, slightly better than the $49.7 million loss in 2025, with basic and diluted net loss per share of $0.52 versus $0.58. A higher income tax provision of $26.5 million weighed on results.
Operating cash flow was negative $8.9 million, an improvement from negative $11.4 million. Cash, cash equivalents and restricted cash were $89.9 million and long-term debt remained at $125.0 million, with an undrawn revolving facility and significant inventory purchase commitments supporting future demand.
MaxLinear, Inc. reported strong first quarter 2026 results and amended its senior secured revolving credit facility. Net revenue was $137.2 million, up 1% sequentially and 43% year over year, with infrastructure revenue up 136% year over year and now the largest end market.
On a GAAP basis, the company posted a net loss of $45.1 million (diluted loss per share of $0.52), while non-GAAP net income was $19.4 million with non-GAAP diluted earnings per share of $0.22. Non-GAAP operating margin was 16% of net revenue.
For second quarter 2026, MaxLinear expects net revenue of $160 million to $170 million, with GAAP gross margin of 56.0%–59.0% and non-GAAP gross margin of 58.0%–61.0%. The company also expects GAAP operating expenses of $91 million to $97 million and non-GAAP operating expenses of $61 million to $66 million.
Separately, MaxLinear entered into a Second Amendment to its Credit Agreement, extending the Revolving Facility maturity from June 23, 2026 to March 23, 2028 and increasing total revolving commitments by $30 million to $130 million. As of the amendment closing, the Revolving Facility was undrawn. The amendment adds covenants requiring a total net leverage ratio not greater than 3.50 to 1.00 and minimum liquidity of $80 million, tested quarterly.
MaxLinear, Inc. is asking stockholders to vote at its 2026 annual meeting on May 20, 2026 at 8:30 a.m. Pacific Time in Carlsbad, California. Holders of the 89,529,216 shares of common stock outstanding as of March 23, 2026 may vote.
Stockholders are asked to elect two Class II directors (Carolyn Beaver and Theodore Tewksbury) to terms ending in 2029, approve on an advisory basis 2025 executive compensation, and ratify Grant Thornton LLP as independent auditor for 2026. The board uses a majority voting standard in uncontested director elections.
The company also seeks approval of an amended and restated 2010 Equity Incentive Plan with a new ten-year term and an increase of 3,204,107 shares reserved, bringing approximately 5,000,000 shares available for issuance if approved. Approval would lead to termination of the Inducement Equity Incentive Plan and movement of 3,127,896 available inducement shares plus an incremental 76,211 shares into a single plan, which the company states will not cause significant additional dilution and is expected to cover equity needs through May 2027.
Stockholders are further asked to approve an amended and restated 2010 Employee Stock Purchase Plan with a new term. The proxy details board structure, committee responsibilities, director and executive stock ownership guidelines, an updated clawback policy, and director compensation, including annual cash retainers and equity awards.
MaxLinear Inc ownership disclosure: The Vanguard Group amended its Schedule 13G to report 0 shares beneficially owned of MaxLinear common stock following an internal realignment.
The filing states certain Vanguard subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538 (January 12, 1998). The amendment is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
MAXLINEAR, INC officer Steven G. Litchfield reported selling a total of 44,929 shares of MaxLinear common stock in open-market transactions. The sales occurred on March 4, 5, and 6, 2026, at weighted average prices of $17.4959, $16.8061, and $15.6836 per share, respectively.
After these sales, he directly owned 343,435 shares of MaxLinear common stock. This holding includes 326 shares acquired under the company’s 2010 Employee Stock Purchase Plan on November 15, 2025, as noted in the filing footnotes.
Steven Litchfield reported sales of Common stock. The filing lists a sale of 20,000 shares on 03/04/2026 for $349,918.00 and a sale of 4,929 shares on 03/05/2026 for $82,837.27. The record also shows 20,000 restricted shares dated 02/20/2025.
Steven Litchfield sold 20,000 shares of Common stock as reported on 03/04/2026. The filing shows the sale value at $349,918.00 and lists the securities sold as Restricted Stock acquired 02/20/2025.
MXL: Morgan Stanley Smith Barney LLC filed a Form 144 to sell 20,000 shares of common stock. The filing lists restricted stock lots from 08/20/2019 (8,505 shares), 11/20/2019 (2,127 shares), 02/20/2020 (1,922 shares), 05/20/2024 (1,517 shares) and 02/20/2025 (5,929 shares) as the source of the shares to be sold.
MaxLinear, Inc. Corporate Controller & PAO Connie H. Kwong reported multiple equity award transactions on March 2, 2026. Several batches of restricted stock units were converted into common stock, while portions of the resulting shares were withheld at a price of $17.99 per share to cover tax obligations. After these exercises and tax-withholding dispositions, Kwong directly owned 68,115 shares of MaxLinear common stock.